Physician profile
Daryl F Mann
NPI 1477557148
$4,758.81
in general payments reported to CMS, 2019-2025
18 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $997 · 2020: $1,084 · 2021: $403 · 2022: $253 · 2023: $618 · 2024: $1,131 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,515 · Travel and Lodging: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.85 |
| Travel and Lodging | $506.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,114.05 | 2019-2025 | Tecnis Iol, Veritas Vision System, Tecnis Simplicity |
| Alcon Vision LLC | $1,472.68 | 2019-2024 | Wavelight Refractive Suite, Clareon, Argos |
| Eyevance Pharmaceuticals LLC | $200.69 | 2019-2020 | |
| Ziemer USA | $162.09 | 2023 | Femtoldv |
| Allergan, INC. | $132.03 | 2020-2021 | |
| Carl Zeiss Meditec USA, INC. | $129.52 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.93 | 2019 | |
| Genentech USA, INC. | $76.48 | 2023-2024 | Vabysmo, Lucentis |
| Coopervision INC. | $67.99 | 2019 | |
| Mallinckrodt Hospital Products INC. | $60.44 | 2021-2025 | Acthar |
| Optos, INC. | $56.04 | 2020 | |
| Mallinckrodt Enterprises LLC | $54.14 | 2019 | |
| Dompe US, INC. | $33.03 | 2019-2021 | |
| Abbvie INC. | $27.89 | 2024 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $18.31 | 2019 | |
| Horizon Therapeutics Plc | $17.92 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $16.18 | 2023 | Eylea |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryl Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.